New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

Today's Free Fly Stories
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | all day >>
07:59 EDTAZZAZZ Inc. reports Q2-end backlog $329.1M
07:59 EDTHTLDHeartland Express coverage resumed with a Market Perform at Wells Fargo
Subscribe for More Information
07:58 EDTAZZAZZ Inc. backs FY15 EPS $2.40-$2.80, consensus $2.62
Subscribe for More Information
07:58 EDTENVEnvestnet completes acquisition of Placemark Investments for $66M
Subscribe for More Information
07:57 EDTCHRWC.H. Robinson coverage resumed with a Market Perform at Wells Fargo
Subscribe for More Information
07:56 EDTLMT, BA, RTN, NOC, GD, BAESY, UTXSyrian strikes sure to prompt calls to reconsider defense cuts, WSJ says
The expanded U.S. military campaign in the Middle East, including airstrikes in Syria, is expected to cost tens of billions of dollars in the short-term and is certain to put renewed pressure on the president and Congress to reconsider spending caps on the defense budget, according to The Wall Street Journal. Publicly traded companies in the Defense space include BAE Systems (BAESY), Boeing (BA), General Dynamics (GD), Lockheed Martin (LMT), Northrop Grumman (NOC), Raytheon (RTN) and United Technologies (UTX). Reference Link
07:54 EDTBRKSBrooks Automation acquires FluidX for approximately $16M
Subscribe for More Information
07:54 EDTKTWOK2M Group valuation compelling at current levels, says Piper Jaffray
Subscribe for More Information
07:52 EDTACHN, JNJ, ABBV, BMYJ&J purchase of Alios an incremental negative for Achillion, says UBS
UBS views Johnson & Johnson's (JNJ) purchase of Alios as an incremental negative for Achillion (ACHN), as it implies there is now one less potential buyer of the company. However, the firm still thinks ACH-3422 will have considerable strategic value after data is reported and that other HCV players such as AbbVie (ABBV) and Bristol-Myers (BMY) are likely to be interested. UBS maintains its Buy rating and $15 price target on Achillion.
07:51 EDTNNVCNanoViricides volatility elevated into CDC confirms first U.S. Ebola case
Subscribe for More Information
07:51 EDTLDOSLeidos awarded $14M contract by DARPA
Subscribe for More Information
07:50 EDTIMPVImperva Q3 revenue likely at higher end of guidance, says Oppenheimer
After conducting checks, Oppneheimer says that Imperva had a solid close to Q3 with a strong pipeline building into Q4. The firm expects the company's Q3 revenue to come in at the upper portion of its guidance range, and it views the stock's valuation as compelling. Oppenheimer keeps an Outperform rating on the shares.
07:50 EDTVRTXVertex reinstated with a Neutral at BofA/Merrill
Subscribe for More Information
07:50 EDTU.S. MBA mortgage market index fell 0.2%
Subscribe for More Information
07:50 EDTU.S. ADP employment survey preview:
U.S. ADP employment survey preview: ADP private jobs are expected to increase 195k in September (median 207k) from 204k in August. That was the fifth straight increase above 200k and was marked by an increase of 78k in small business staff, 75k in medium and 52k in large. For more detail, see the ADP website.
07:49 EDTREGNRegeneron reinstated with a Buy at BofA/Merrill
Subscribe for More Information
07:49 EDTGILDGilead reinstated with a Buy at BofA/Merrill
Subscribe for More Information
07:47 EDTFLRFluor upgraded to Buy from Neutral at DA Davidson
DA Davidson upgraded Fluor to Buy based on valuation, continued execution and growth, and improving industry fundamentals Price target is $85.
07:46 EDTMTGE, MTGEAmerican Capital Mortgage to hold a meeting
Subscribe for More Information
07:45 EDTMDT, COVMedtronic has upside in multiple scenarios, says BofA/Merrill
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | all day >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use